Herlyn M - Search Results

1

Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma.

Villanueva J, Infante JR, Krepler C, Reyes-Uribe P, Samanta M, Chen HY, Li B, Swoboda RK, Wilson M, Vultur A, Fukunaba-Kalabis M, Wubbenhorst B, Chen TY, Liu Q, Sproesser K, DeMarini DJ, Gilmer TM, Martin AM, Marmorstein R, Schultz DC, Speicher DW, Karakousis GC, Xu W, Amaravadi RK, Xu X, Schuchter LM, Herlyn M, Nathanson KL. Villanueva J, et al. Among authors: herlyn m. Cell Rep. 2013 Sep 26;4(6):1090-9. doi: 10.1016/j.celrep.2013.08.023. Epub 2013 Sep 19. Cell Rep. 2013. PMID: 24055054 Free PMC article.

2

Characterization of tenascin secreted by human melanoma cells.

Herlyn M, Graeven U, Speicher D, Sela BA, Bennicelli JL, Kath R, Guerry D 4th. Herlyn M, et al. Cancer Res. 1991 Sep 15;51(18):4853-8. Cancer Res. 1991. PMID: 1716515

3

Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells.

Menrad A, Speicher D, Wacker J, Herlyn M. Menrad A, et al. Among authors: herlyn m. Cancer Res. 1993 Mar 15;53(6):1450-5. Cancer Res. 1993. PMID: 8095183

4

Isolation and functional characterization of the A32 melanoma-associated antigen.

Shih IM, Elder DE, Speicher D, Johnson JP, Herlyn M. Shih IM, et al. Among authors: herlyn m. Cancer Res. 1994 May 1;54(9):2514-20. Cancer Res. 1994. PMID: 8162602

5

Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion.

Shih IM, Speicher D, Hsu MY, Levine E, Herlyn M. Shih IM, et al. Among authors: herlyn m. Cancer Res. 1997 Sep 1;57(17):3835-40. Cancer Res. 1997. PMID: 9288796

6

Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.

Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL, Van Belle P, Elder DE, Herlyn M. Satyamoorthy K, et al. Among authors: herlyn m. Cancer Res. 2003 Feb 15;63(4):756-9. Cancer Res. 2003. PMID: 12591721

7

BRAF as a potential therapeutic target in melanoma and other malignancies.

Tuveson DA, Weber BL, Herlyn M. Tuveson DA, et al. Among authors: herlyn m. Cancer Cell. 2003 Aug;4(2):95-8. doi: 10.1016/s1535-6108(03)00189-2. Cancer Cell. 2003. PMID: 12957284 Free article. Review. No abstract available.

8

Reciprocal regulation of MelCAM and AKT in human melanoma.

Li G, Kalabis J, Xu X, Meier F, Oka M, Bogenrieder T, Herlyn M. Li G, et al. Among authors: herlyn m. Oncogene. 2003 Oct 9;22(44):6891-9. doi: 10.1038/sj.onc.1206819. Oncogene. 2003. PMID: 14534536

9

Absence of BRAF mutations in UV-protected mucosal melanomas.

Edwards RH, Ward MR, Wu H, Medina CA, Brose MS, Volpe P, Nussen-Lee S, Haupt HM, Martin AM, Herlyn M, Lessin SR, Weber BL. Edwards RH, et al. Among authors: herlyn m. J Med Genet. 2004 Apr;41(4):270-2. doi: 10.1136/jmg.2003.016667. J Med Genet. 2004. PMID: 15060100 Free PMC article.

10

Functional erythropoietin autocrine loop in melanoma.

Kumar SM, Acs G, Fang D, Herlyn M, Elder DE, Xu X. Kumar SM, et al. Among authors: herlyn m. Am J Pathol. 2005 Mar;166(3):823-30. doi: 10.1016/S0002-9440(10)62303-6. Am J Pathol. 2005. PMID: 15743794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

677 results

Search Page